Furthermore, these two groups of patients showed similar proportion of overweight, elevated blood pressure, elevated fasting glucose, higher level of IGF-1, IGFBP-3, insulin, C-peptide, elevated triglycerides, reduced HDL-C, and MetS (all P > 0.05). The gene discussed is IGFBP3; the disease is metabolic syndrome.